Register for email alerts and news feeds:
This journal | BMJ Group
rss
The most recent version of this article was published on 1 May 2007

Ann Rheum Dis. Published Online First: 26 February 2007. doi:10.1136/ard.2006.067629
Copyright © 2007 BMJ Publishing Group Ltd & European League Against Rheumatism.

Letter

Effectiveness of an once weekly double dose of etanercept in patients with JIA: a clinical study

Femke H.M. Prince 1*, Marinka Twilt 2, Nelleke C. J. A. Jansen-Wijngaarden 1 and Lisette W.A. van Suijlekom-Smit 1

1 Erasmus MC Sophia Children's Hospital, Netherlands
2 Erasmus MC Sophia Children's Hospital/ Leiden University Medical Center, Netherlands

* To whom correspondence should be addressed. E-mail: f.prince{at}erasmusmc.nl.

Accepted 19 February 2007


Abstract

Etanercept is effective in Juvenile Idiopathic Arthritis (JIA).[1-3] Currently it is administered subcutaneously (SC) in the dose of 0,4 mg/kg (maximum of 25 mg) twice weekly. Clinical trials in adults show that the administering of an once weekly double dose is effective enough to induce and retain remission.[4, 5] A farmakinetic model developed by Yim et al. indicates that the same dosing regime could be used in children. [6] Wallace mentions the once weekly double dose in patients with JIA, but this is not supported by clinical trials.[7] Therefore we evaluated the efficacy of etanercept administered once weekly in the dose of 0,8 mg/kg SC (maximum of 50 mg) to retain and induce remission in patients with JIA.

Keywords: Juvenile Idiopathic Arthritis, double dose, etanercept, once weekly


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

This article has been cited by other articles:

  • Horneff, G., Ebert, A., Fitter, S., Minden, K., Foeldvari, I., Kummerle-Deschner, J., Thon, A., Girschick, H. J., Weller, F., Huppertz, H. I. (2009). Safety and efficacy of once weekly etanercept 0.8 mg/kg in a multicentre 12 week trial in active polyarticular course juvenile idiopathic arthritis. Rheumatology (Oxford) 48: 916-919 [Abstract] [Full Text]  
  • Prince, F H M, Twilt, M, Cate, R t., van Rossum, M A J, Armbrust, W, Hoppenreijs, E P A H, van Santen-Hoeufft, M, Koopman-Keemink, Y, Wulffraat, N M, van Suijlekom-Smit, L W A (2009). Long-term follow-up on effectiveness and safety of etanercept in juvenile idiopathic arthritis: the Dutch national register. Ann Rheum Dis 68: 635-641 [Abstract] [Full Text]  

This Article

Services
Citing Articles
Google Scholar
PubMed
Bookmark with

Register for free content

The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.

BMJ Careers - Latest Rheumatology Jobs

Rheumatology Jobs